Genetic testing of common and rare variants in dementia patients from a memory clinic
this study highlights the potential of integrating genetic risk factors into clinical practice to enhance AD diagnosis, though the improvement in diagnostic accuracy was moderate.
14/10/2025/door jetskevanderschaarDeciding on genetic testing for familial dementia: Perspectives of patients and families
The vast majority of cognitively normal adults participating in a research registry expresses interest in AD genetic risk research and disclosure
05/03/2025/door jetskevanderschaarPrevalence of Pathogenic Variants and Eligibility Criteria for Genetic Testing in Patients Who Visit a Memory Clinic
The vast majority of cognitively normal adults participating in a research registry expresses interest in AD genetic risk research and disclosure
27/01/2025/door jetskevanderschaarThe need for personalization when sharing results of amyloid imaging for Alzheimer’s disease: Insights from a randomized experimental study
The vast majority of cognitively normal adults participating in a research registry expresses interest in AD genetic risk research and disclosure
25/11/2024/door jetskevanderschaarAmyloid PET disclosure in subjective cognitive decline: Patient experiences over time
The vast majority of cognitively normal adults participating in a research registry expresses interest in AD genetic risk research and disclosure
02/07/2024/door jetskevanderschaarInterest in genetic susceptibility testing and disclosure of AD dementia risk in cognitively normal adults: a survey study
The vast majority of cognitively normal adults participating in a research registry expresses interest in AD genetic risk research and disclosure
02/01/2024/door jetskevanderschaar